Detection and Isolation of Tissue-Specific Extracellular Vesicles From the Blood
- PMID: 40552103
- PMCID: PMC12183346
- DOI: 10.1002/jex2.70059
Detection and Isolation of Tissue-Specific Extracellular Vesicles From the Blood
Abstract
Extracellular vesicles (EVs) are nanosized, membrane-bound particles released by virtually all cell types, serving as messengers within tissues and across organs via the bloodstream. EVs encapsulate diverse molecular cargo that reflects the phenotypic state of their originating cells, making them promising candidates for liquid biopsy applications. However, the heterogeneity of circulating EVs, comprising particles from various cell types and non-vesicular entities like lipoproteins, poses significant challenges for isolating tissue-specific EV populations. This review examines current methodologies for detecting and isolating tissue-specific EVs from blood, focusing on immunoaffinity capture (IAC) strategies that leverage surface marker expression for specificity. Key considerations, including the selection and validation of markers, are discussed alongside advances in EV subtyping and isolation protocols. Challenges such as marker cross-reactivity, EV biogenesis and transport dynamics are highlighted to underscore the complexity of achieving clinical utility. By providing an overview of validated tissue-specific markers and isolation techniques, this review aims to facilitate the development of EV-based biomarkers with enhanced specificity and sensitivity, enabling minimally invasive monitoring of organ function and disease.
Keywords: EV subtypes; cell origin; extracellular vesicles; immunoaffinity isolation; organ‐derived; tissue‐specific.
© 2025 The Author(s). Journal of Extracellular Biology published by Wiley Periodicals, LLC on behalf of the International Society for Extracellular Vesicles.
Conflict of interest statement
Andrew Rowland and Lauren Newman are recipients of research funding from Pfizer Inc., AstraZeneca and Boehringer Ingelheim for work outside of the scope of this project. The other authors declare no conflicts of interest.
Figures

Similar articles
-
Extracellular Vesicles: Recent Advances and Perspectives.Front Biosci (Landmark Ed). 2025 May 30;30(6):36405. doi: 10.31083/FBL36405. Front Biosci (Landmark Ed). 2025. PMID: 40613286 Review.
-
Unveiling Invisible Extracellular Vesicles: Cutting-Edge Technologies for Their in Vivo Visualization.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Sep-Oct;16(5):e2009. doi: 10.1002/wnan.2009. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024. PMID: 39439198 Free PMC article. Review.
-
Extracellular vesicles as nature's nano carriers in cancer therapy: Insights toward preclinical studies and clinical applications.Pharmacol Res. 2025 Jul;217:107751. doi: 10.1016/j.phrs.2025.107751. Epub 2025 May 7. Pharmacol Res. 2025. PMID: 40345354 Review.
-
Systematic Evaluation of Isolation Techniques and Freeze-Thaw Effects on Plasma Extracellular Vesicle Heterogeneity and Subpopulation Profiling.J Extracell Biol. 2025 Jun 26;4(6):e70058. doi: 10.1002/jex2.70058. eCollection 2025 Jun. J Extracell Biol. 2025. PMID: 40575388 Free PMC article.
-
Extracellular Vesicle-Integrated Biomaterials in Bone Tissue Engineering Applications: Current Progress and Future Perspectives.Int J Nanomedicine. 2025 Jun 17;20:7653-7683. doi: 10.2147/IJN.S522198. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40546799 Free PMC article. Review.
References
-
- Agliardi, C. , Guerini F. R., Zanzottera M., et al. 2024. “Increased Concentrations of P2×7R in Oligodendrocyte Derived Extracellular Vesicles of Multiple Sclerosis Patients.” Neurobiology of Disease 199: 106601. - PubMed
Publication types
LinkOut - more resources
Full Text Sources